S&P 500   3,286.11 (+0.30%)
DOW   28,842.25 (+0.42%)
QQQ   222.03 (+0.26%)
AAPL   327.29 (+3.02%)
FB   221.88 (+1.88%)
MSFT   167.20 (+1.05%)
GOOGL   1,455.17 (+0.32%)
AMZN   1,863.21 (+0.54%)
CGC   24.16 (+1.00%)
NVDA   244.47 (-1.41%)
BABA   210.39 (+0.08%)
MU   55.87 (-1.06%)
TSLA   572.20 (+0.93%)
AMD   46.38 (-8.21%)
T   37.39 (-3.08%)
NFLX   345.15 (-0.97%)
BAC   33.35 (+0.33%)
DIS   136.81 (-1.13%)
S&P 500   3,286.11 (+0.30%)
DOW   28,842.25 (+0.42%)
QQQ   222.03 (+0.26%)
AAPL   327.29 (+3.02%)
FB   221.88 (+1.88%)
MSFT   167.20 (+1.05%)
GOOGL   1,455.17 (+0.32%)
AMZN   1,863.21 (+0.54%)
CGC   24.16 (+1.00%)
NVDA   244.47 (-1.41%)
BABA   210.39 (+0.08%)
MU   55.87 (-1.06%)
TSLA   572.20 (+0.93%)
AMD   46.38 (-8.21%)
T   37.39 (-3.08%)
NFLX   345.15 (-0.97%)
BAC   33.35 (+0.33%)
DIS   136.81 (-1.13%)
S&P 500   3,286.11 (+0.30%)
DOW   28,842.25 (+0.42%)
QQQ   222.03 (+0.26%)
AAPL   327.29 (+3.02%)
FB   221.88 (+1.88%)
MSFT   167.20 (+1.05%)
GOOGL   1,455.17 (+0.32%)
AMZN   1,863.21 (+0.54%)
CGC   24.16 (+1.00%)
NVDA   244.47 (-1.41%)
BABA   210.39 (+0.08%)
MU   55.87 (-1.06%)
TSLA   572.20 (+0.93%)
AMD   46.38 (-8.21%)
T   37.39 (-3.08%)
NFLX   345.15 (-0.97%)
BAC   33.35 (+0.33%)
DIS   136.81 (-1.13%)
S&P 500   3,286.11 (+0.30%)
DOW   28,842.25 (+0.42%)
QQQ   222.03 (+0.26%)
AAPL   327.29 (+3.02%)
FB   221.88 (+1.88%)
MSFT   167.20 (+1.05%)
GOOGL   1,455.17 (+0.32%)
AMZN   1,863.21 (+0.54%)
CGC   24.16 (+1.00%)
NVDA   244.47 (-1.41%)
BABA   210.39 (+0.08%)
MU   55.87 (-1.06%)
TSLA   572.20 (+0.93%)
AMD   46.38 (-8.21%)
T   37.39 (-3.08%)
NFLX   345.15 (-0.97%)
BAC   33.35 (+0.33%)
DIS   136.81 (-1.13%)
Log in

BioMarin Pharmaceutical SEC Filings & 10K Form (NASDAQ:BMRN)

$86.43
+0.54 (+0.63 %)
(As of 01/29/2020 11:55 AM ET)
Today's Range
$86.16
Now: $86.43
$87.08
50-Day Range
$78.51
MA: $85.52
$91.10
52-Week Range
$62.88
Now: $86.43
$100.13
Volume36,915 shs
Average Volume1.21 million shs
Market Capitalization$15.53 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.32

SEC Filings

BioMarin Pharmaceutical (NASDAQ:BMRN) SEC Filings

DateFilerForm TypeView
01/16/2020
7:00 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2020
3:44 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2019
6:27 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
7:09 PM
BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
5:47 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
12:34 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
6:36 AM
BioMarin Pharmaceutical (Filer)
Form 10-Q/A
10/29/2019
6:16 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2019
11:58 AM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2019
3:17 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
3:17 PM
BioMarin Pharmaceutical (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/30/2019
7:16 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
5:47 PM
BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
6:34 PM
BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
5:10 AM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
3:15 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
6:09 PM
BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
5:41 PM
ANDERSON ELIZABETH M (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
5:01 PM
ANDERSON ELIZABETH M (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2019
4:00 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
11:27 AM
BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
6:03 PM
BAFFI ROBERT (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
6:14 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
6:08 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
5:52 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
5:51 PM
BioMarin Pharmaceutical (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
5:48 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
4:00 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
5:17 PM
BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:13 PM
BioMarin Pharmaceutical (Issuer)
HOMBACH ROBERT J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:12 PM
BioMarin Pharmaceutical (Issuer)
Dere Willard H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:10 PM
BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:06 PM
BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
4:58 PM
BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
4:55 PM
BioMarin Pharmaceutical (Issuer)
LEWIS ALAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
4:53 PM
BioMarin Pharmaceutical (Issuer)
GREY MICHAEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
4:47 PM
BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
4:07 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
4:07 PM
BAFFI ROBERT (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2019
6:15 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
6:08 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
7:32 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
7:09 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2019
5:08 AM
BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
3:15 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2019
3:16 PM
BioMarin Pharmaceutical (Filer)
Form DEFA14A
04/23/2019
3:15 PM
BioMarin Pharmaceutical (Filer)
Form DEF 14A
04/18/2019
6:25 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2019
7:26 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
5:23 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
5:12 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
5:10 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
12:17 PM
BioMarin Pharmaceutical (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
5:30 PM
BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
5:19 PM
BioMarin Pharmaceutical (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
5:07 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2019
4:59 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
7:51 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
7:44 PM
BAFFI ROBERT (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
7:37 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
7:30 PM
BioMarin Pharmaceutical (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
7:20 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
7:01 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2019
6:51 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
4:18 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
4:01 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
4:00 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
4:00 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:43 PM
BioMarin Pharmaceutical (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:26 PM
BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
7:15 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
6:39 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
6:21 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
5:55 PM
BAFFI ROBERT (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
5:41 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
1:35 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
7:00 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
7:34 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
4:45 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
7:08 PM
BioMarin Pharmaceutical (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:58 PM
BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:47 PM
BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:37 PM
Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:28 PM
BAFFI ROBERT (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
6:16 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
7:24 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:24 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:15 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
6:06 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2019
5:21 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/11/2019
10:45 AM
BioMarin Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/07/2019
6:21 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
3:21 PM
BioMarin Pharmaceutical (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
01/31/2019
11:00 AM
BioMarin Pharmaceutical (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G/A
01/24/2019
6:07 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
6:43 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2019
2:30 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2019
5:50 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
1:55 PM
BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
3:15 PM
BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 1/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel